ChemInform Abstract: Human β3-Adrenergic Receptor Agonists Containing 1,2,3-Triazole-Substituted Benzenesulfonamides.
Abstract
ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
ChemInform Abstract
Different substitution patterns of the triazole ring are explored with preference of 2,4-disubstitution. The prepared compounds (IV) and (X), in which fluorinated aromatic rings are substituted for aliphatic side chains, are analogues of potent and selective β3-adrenergic receptor agonists. The new agonists show markedly improved oral bioavailabilities while maintaining potency, selectivity, and in vivo efficacy. In particular, compound (X), which is an exceptionally selective human β3-agonist, reveals 6500- and 1500-fold selectivity over binding to β1 and β2 receptors, respectively.